Clinical feasibility of duodenum-preserving pancreatic head resection for neuroendocrine tumors of the pancreatic head as an intermediate procedure between enucleation and pancreaticoduodenectomy
Fujita Medical Journal · 2024-08 · 10 (3) · 69-74
DOI: 10.20407/fmj.2023-017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fujita Medical Journal, 2024-08. Verfasst von Masahiro Shimura und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Fujita Health University, School of Medicine, Nagoya, Aichi, Japan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
This study was performed to demonstrate the clinical application of duodenum-preserving pancreatic head resection (DPPHR) as a surgical treatment for pancreatic neuroendocrine tumors (PNETs) in terms of both curability and maintenance of postoperative quality of life.
Methods
Seven patients diagnosed with PNETs underwent DPPHR from January 2011 to December 2021 at our institution. We investigated the clinical relevance of DPPHR based on the patients’ clinicopathological findings.
Results
The median operative time was 492 min, and the median blood loss was 302 g. Postoperative complications were evaluated according to the Clavien–Dindo classification, and postoperative intra-abdominal bleeding was observed in one patient. Pathological examination revealed a World Health Organization classification of G1 in six patients and G2 in one patient. Microvascular invasion was observed in two patients (29%); however, no patients developed lymph node metastasis or recurrence during the follow-up period. A daughter lesion was observed near the primary tumor in one patient. All patients achieved curative resection, and no tumor specimens showed positive margins.
Conclusions
DPPHR facilitates anatomical resection of the pancreatic head in patients with PNETs as well as detailed pathological evaluation of the resected specimen. Therefore, this surgical procedure is an acceptable alternative to pancreaticoduodenectomy or enucleation for patients with PNETs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Fujita Health University, School of Medicine, Nagoya, Aichi, Japan.
Zitieren
APA
Shimura, M., Kato, H., Asano, Y., Nagata, H., Kondo, Y., Arakawa, S., Koike, D., Ochi, T., Yasuoka, H., Kawai, T., Higashiguchi, T., Tani, H., Kunimura, Y., Horiguchi, K., Kato, Y., Ito, M., Hanai, T., & Horiguchi, A. (2024). Clinical feasibility of duodenum-preserving pancreatic head resection for neuroendocrine tumors of the pancreatic head as an intermediate procedure between enucleation and pancreaticoduodenectomy. Fujita Medical Journal, 10(3), 69-74. https://doi.org/10.20407/fmj.2023-017
Vancouver
Shimura M, Kato H, Asano Y, Nagata H, Kondo Y, Arakawa S, et al. Clinical feasibility of duodenum-preserving pancreatic head resection for neuroendocrine tumors of the pancreatic head as an intermediate procedure between enucleation and pancreaticoduodenectomy. Fujita Medical Journal. 2024;10(3):69-74. doi:10.20407/fmj.2023-017
BibTeX
@article{Shimura2024,
author = {Shimura, Masahiro and Kato, Hiroyuki and Asano, Yukio and Nagata, Hidetoshi and Kondo, Yuka and Arakawa, Satoshi and Koike, Daisuke and Ochi, Takayuki and Yasuoka, Hironobu and Kawai, Toki and Higashiguchi, Takahiko and Tani, Hiroki and Kunimura, Yoshiki and Horiguchi, Kazuma and Kato, Yutaro and Ito, Masahiro and Hanai, Tsunekazu and Horiguchi, Akihiko},
title = {Clinical feasibility of duodenum-preserving pancreatic head resection for neuroendocrine tumors of the pancreatic head as an intermediate procedure between enucleation and pancreaticoduodenectomy},
journal = {Fujita Medical Journal},
year = {2024},
volume = {10},
number = {3},
pages = {69--74},
doi = {10.20407/fmj.2023-017}
}
EUVIMED